Transhumanism is moving from speculation to practice: neural interfaces, synthetic biology, and longevity stacks are redefining capability. This hub gives builders and researchers a high-signal view of how biology and code converge without sacrificing agency and identity.
From wetware to software, we map systems, incentives, and risks behind human–AI symbiosis—so upgrades respect privacy, consent, and control.
Why Transhumanism matters now
BCIs exit the lab, gene editing compresses development cycles, and prevention-first longevity protocols mainstream biomarkers. The trajectory is shifting from treating disease to upgrading baselines, demanding new guardrails for consent, safety, and biometric data stewardship. See GDPR and the W3C Privacy Principles for anchors.
Ethics & governance for Transhumanism
- Neuro-rights — mental privacy, identity continuity, and meaningful consent by default.
- Safety & access — equitable trials, bias mitigation, post-market monitoring, and affordability.
- Data stewardship — biometric minimization, portability, auditability, and strict retention limits.
Design for safety and agency first: standardize consent UX, publish red-team results, and document model/data provenance for each device and update cycle. For adjacent perspectives, see our hubs on AI Privacy and Digital Dystopia.
FAQ
Is it only for the rich? Not if standards and public funding prioritize safety, access, and transparency across clinical and consumer paths.
Will BCIs replace phones? They will augment first (assistive/control layers), then converge with wearables and edge AI; form factors will diversify as input/output stabilizes.
Where to begin? Start with the BCI field guide above, then explore longevity and synthetic biology to understand trade-offs, timelines, and regulatory realities.